retatrutide fat loss trial A new weight-loss drug called is generating excitement after clinical participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also Phase III retatrutide study demonstrates
Description
Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial

Karen Mann, an OB-GYN and Nooms Medical Director, shares her expertise on managing menopausal weight gain and what role hormone replacement therapy (HRT) may play

Case This is a 44-year-old woman who presented in 2017 for evaluation of breast cancer-related lymphedema due to arm swelling

Even when SYMLIN is carefully added to your mealtime insulin therapy, your blood sugar may drop too low, especially if you have type 1 diabetes

How are the pills different from the injections
Pens may not require separate syringes, while vials or compounded formats may require syringe supplies
